GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cadence Pharmaceuticals, Inc. (CADX) [hlAlert]

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing its product candidates principally for use in the hospital setting. The Company has in-licensed rights to two
late stage product candidates, Acetavance a intravenous formulation of acetaminophen and Omigard (omiganan pentahydrochloride) 1% aqueous gel. It has in-licensed the exclusive United States and Canadian rights to Acetavance, that is marketed in Europe for the treatment of acute pain and fever by Bristol-Myers Squibb Company (BMS). The Company has also in-licensed the rights to commercialize Omigard in North American and Europe.
.
( Total: 15 Current Stock Recommendations )
Cadence Pharmaceuticals, Inc.   (15)
Sell Hold 33% Buy 60%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Hold CADX

Rating:
Hold CADX
up 76.51 %

Rating:
Hold CADX

Rating:
Buy CADX
up 96.34 %

Rating:
Buy CADX
up 99.71 %

Rating:
Buy CADX
up 108.65 %

Rating:
Hold CADX

Rating:
Hold CADX

Rating:
None
3 Months Gains
up 133.85 %
Cadence Pharmaceuticals, Inc. (CADX) rated Perform by Oppenheimer
Thursday,  Nov 17, 2011  8:25 AM ET

Rating:
Buy CADX
up 196.18 %

Rating:
Buy CADX
up 107.11 %

Rating:
Hold CADX

Rating:
Sell CADX
down 42.34 %

Rating:
Buy CADX
up 76.51 %

Your Recent Stocks
SymbolLastChange
CADX 13.98   0.00 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy